Think Bioscience Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$55M
- Investors
-
19
Think Bioscience General Information
Description
Developer of reimagining synthetic biology systems designed to guide the design and assembly of better medicines. The company's technology encodes a sophisticated molecular objective into a microbial host to identify, build, and evolve small molecules, enabling medical researchers to use microbes in drug discovery.
Contact Information
Website
www.thinkbioscience.comCorporate Office
- 1745 38th Street
- Suite 150
- Boulder, CO 80301
- United States
Corporate Office
- 1745 38th Street
- Suite 150
- Boulder, CO 80301
- United States
Think Bioscience Timeline
Think Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series A) | 20-Jan-2026 | $55M | Completed | Generating Revenue | ||
| 7. Seed Round | 06-May-2024 | Completed | Generating Revenue | |||
| 6. Grant | 25-Nov-2022 | Completed | Generating Revenue | |||
| 5. Seed Round | 18-Aug-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 15-Oct-2021 | Completed | Generating Revenue | |||
| 3. Grant | 17-Dec-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 30-Nov-2020 | $250K | $250K | Completed | Generating Revenue | |
| 1. Grant | 23-Nov-2020 | $125K | Completed | Generating Revenue |
Think Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Seed-2A | ||||||||
| Seed-2 | ||||||||
| Seed-1D | ||||||||
| Seed-1C | ||||||||
| Seed-1B | 1,466,606 | $0.000010 | $0.44 | $0.44 | 1x | $0.44 | 0.64% | |
| Seed-1A | 940,203 | $0.000010 | $0.27 | $0.27 | 1x | $0.27 | 0.41% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Think Bioscience Comparisons
Industry
Financing
Details
Think Bioscience Competitors (41)
One of Think Bioscience’s 41 competitors is Generative Tensorial Networks, a Formerly VC-backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Generative Tensorial Networks | Formerly VC-backed | London, United Kingdom | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Second Genome | Formerly VC-backed | Brisbane, CA | ||||
| Mustang Bio | Formerly VC-backed | Waltham, MA | ||||
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA |
Think Bioscience Patents
Think Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3237159-A1 | Methods and systems for high-throughput biochemical screens | Pending | 03-Nov-2021 | ||
| EP-4426882-A1 | Methods and systems for high-throughput biochemical screens | Pending | 03-Nov-2021 | ||
| US-20250034551-A1 | Methods and systems for high-throughput biochemical screens | Pending | 03-Nov-2021 | ||
| WO-2023081783-A1 | Methods and systems for high-throughput biochemical screens | Inactive | 03-Nov-2021 | C12N15/1055 |
Think Bioscience Signals
Think Bioscience Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CE-Ventures | Corporate Venture Capital | Minority | ||
| Janus Henderson Investors | Asset Manager | Minority | ||
| MBX Capital | Venture Capital | Minority | ||
| Regeneron Ventures | Corporate Venture Capital | Minority | ||
| T.A. Springer | Corporation | Minority |
Think Bioscience FAQs
-
When was Think Bioscience founded?
Think Bioscience was founded in 2019.
-
Where is Think Bioscience headquartered?
Think Bioscience is headquartered in Boulder, CO.
-
What is the size of Think Bioscience?
Think Bioscience has 29 total employees.
-
What industry is Think Bioscience in?
Think Bioscience’s primary industry is Drug Discovery.
-
Is Think Bioscience a private or public company?
Think Bioscience is a Private company.
-
What is the current valuation of Think Bioscience?
The current valuation of Think Bioscience is .
-
What is Think Bioscience’s current revenue?
The current revenue for Think Bioscience is .
-
How much funding has Think Bioscience raised over time?
Think Bioscience has raised $78.2M.
-
Who are Think Bioscience’s investors?
CE-Ventures, Janus Henderson Investors, MBX Capital, Regeneron Ventures, and T.A. Springer are 5 of 19 investors who have invested in Think Bioscience.
-
Who are Think Bioscience’s competitors?
Generative Tensorial Networks, Eligo Bioscience, Second Genome, Mustang Bio, and NGM Biopharmaceuticals are some of the 41 competitors of Think Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process